Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation
Authors
Keywords
-
Journal
BMC Pulmonary Medicine
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-12
DOI
10.1186/s12890-021-01671-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The inhibitory effect of human DEFA5 in growth of gastric cancer by targeting BMI1
- (2021) Zhongwei Wu et al. CANCER SCIENCE
- KRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma
- (2021) Nikolaj Frost et al. Translational Lung Cancer Research
- Significance of TP53 Mutation in Cellular Process and Disease Progression in Lung Adenocarcinoma
- (2021) Yongbo Hou et al. Genetic Testing and Molecular Biomarkers
- The novel long noncoding RNA CRART16 confers cetuximab resistance in colorectal cancer cells by enhancing ERBB3 expression via miR-371a-5p
- (2020) Xiaoqian Zhang et al. Cancer Cell International
- Lung Cancer 2020
- (2020) Brett C. Bade et al. CLINICS IN CHEST MEDICINE
- Neuropeptide Y is involved in the regulation of quiescence of hematopoietic stem cells
- (2020) Baris Ulum et al. NEUROPEPTIDES
- Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis
- (2020) Guoshu Bi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs
- (2020) Matteo Canale et al. Journal of Clinical Medicine
- TP53 somatic mutations are associated with poor survival in non-small cell lung cancer patients who undergo immunotherapy
- (2020) Liqin Zhao et al. Aging-US
- Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma
- (2020) Feng Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival
- (2020) Donald Freudenstein et al. Cancers
- Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
- (2020) Hao Sun et al. EBioMedicine
- Genetic and microenvironmental differences in non-smoking lung adenocarcinoma patients compared with smoking patients
- (2020) Qihai Sui et al. Translational Lung Cancer Research
- Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis
- (2020) Jiaqi Liang et al. Translational Lung Cancer Research
- Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma
- (2020) Chengde Wu et al. Cancer Medicine
- Predictive and Prognostic Potential of TP53 in Patients With Advanced Non–Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901)
- (2020) Xiang-Meng Li et al. Clinical Lung Cancer
- Titin mutations and muscle disease
- (2019) Dalma Kellermayer et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- LncRNA TUSC7 suppresses pancreatic carcinoma progression by modulating miR-371a-5p expression
- (2019) Lei Yue et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma
- (2019) Xingyu Cheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma
- (2019) Di-Han Liu et al. ANNALS OF SURGICAL ONCOLOGY
- LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration of non-small cell lung cancer cells by targeting the miR-27b-3p/GSPT1 axis
- (2019) Wen Sun et al. OncoTargets and Therapy
- PGC-1α activator–induced fatty acid oxidation in tumor-infiltrating CTLs enhances effects of PD-1 blockade therapy in lung cancer
- (2019) Huan Wan et al. TUMORI
- Cancer Progress and Priorities: Lung Cancer
- (2019) Matthew B. Schabath et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway
- (2018) Pei-song Bai et al. EXPERIMENTAL CELL RESEARCH
- Characterization and selective incorporation of small non-coding RNAs in non-small cell lung cancer extracellular vesicles
- (2018) Chuang Li et al. Cell and Bioscience
- Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer
- (2018) Yongjie Huang et al. BIOMEDICINE & PHARMACOTHERAPY
- Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer
- (2018) Rui Zhou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- Regulators of Oncogenic Mutant TP53 Gain of Function
- (2018) Satomi Yamamoto et al. Cancers
- Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
- (2016) Zhong-Yi Dong et al. CLINICAL CANCER RESEARCH
- Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8 + T Cell Exhaustion
- (2016) Bertram Bengsch et al. IMMUNITY
- Somatic TP53 Mutations in the Era of Genome Sequencing
- (2016) Pierre Hainaut et al. Cold Spring Harbor Perspectives in Medicine
- Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma
- (2015) Juan Li et al. Cancer Cell International
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- p53 in survival, death and metabolic health: a lifeguard with a licence to kill
- (2015) Flore Kruiswijk et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases
- (2015) Sung-Hyeok Hong et al. Oncotarget
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Reduction of E-cadherin by human defensin-5 in esophageal squamous cells
- (2013) Yoshiki Nomura et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Prognostic value ofTP53,KRASandEGFRmutations in nonsmall cell lung cancer: the EUELC cohort
- (2012) Chiara Scoccianti et al. EUROPEAN RESPIRATORY JOURNAL
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- α-Defensins in human innate immunity
- (2011) Robert I. Lehrer et al. IMMUNOLOGICAL REVIEWS
- TP53 Mutations in Nonsmall Cell Lung Cancer
- (2011) Akira Mogi et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis
- (2011) Charles L. Bevins et al. NATURE REVIEWS MICROBIOLOGY
- ATR-p53 Restricts Homologous Recombination in Response to Replicative Stress but Does Not Limit DNA Interstrand Crosslink Repair in Lung Cancer Cells
- (2011) Bianca M. Sirbu et al. PLoS One
- Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma
- (2010) Takayuki Kosaka et al. Journal of Thoracic Oncology
- Cell of origin of lung cancer
- (2010) Kate D. Sutherland et al. Molecular Oncology
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Human defensins as cancer biomarkers and antitumour molecules
- (2009) Nathalie Droin et al. Journal of Proteomics
- Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
- (2009) J. P. Morton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutant p53 Gain-of-Function in Cancer
- (2009) M. Oren et al. Cold Spring Harbor Perspectives in Biology
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started